All Type of News
MSD, the developing company of simbastatin, will sell atorvastatin from the next month
MSD will launch the atorvastatin and ezetimibe hyperlipidemia complex ‘Atozet’ within the middle of the next month.
Atozet has been approved in 23 January 2015 and secured the base of the launch with the approval of ...
Hanmi Pharm has made a license contract of immunization disease treatments with LillyHanmi Pharm and Eli Lilly announced on the 19th that they have made a license and cooperation contract to develop and commercialize the Hanmi Pharm’s BTK inhibitor, HM71224, rel...
|
9 listed pharmaceutical companies have warning signals on in cash mobilizing power
It is analyzed that 9 listed pharmaceutical companies, such as Myungmoon Pharm, Dong-A Socio Holdings, Hanmi Science, have warning signals on in cash mobilizing power.
According to the YakupDotCom’s analysis result o...
Samsung Medical Center ranked the 1st in preference while Asan and Severance are catching up
In the preference survey for brands of hospitals, Samsung Medical Center ranked the first, leaving Asan Medical Center behind.
Realmeter unveiled the result of the preference survey, the Top 10 Korean Hospital Brands...
Would the 2nd battle break out between Trajenta and Januvia due to the beneficiary standard alteration?
While Trajenta (generic name: linagliptin) is catching up, Januvia (generic name: sitagliptin) is running away; the two products dividing the DDP-4 inhibitor market are reviving its endless chase using the alteration ...
Stock price of Hanmi Pharm increased 65% up in a monthWould it be the precursor predicting the new drug project, titled ‘Quantum Jump’?
Stock price of Hanmi Pharm has significantly increased. The increase was 65% up in a month.
T...
|
Kunwha Pharmaceutical decided to merger ‘Dream Pharma’
The Kunwha Pharmaceutical’s merger with Dream Pharm has been decided.
Kunwha Pharmaceutical announced on the 17th that it decided to merger its 100% affiliated company, Dream Pharma Inc. (Kunwha Pharmaceutical owns 1...
When the pharmaceutical environment is unreliable, listed pharmaceutical companies focus on collecting cashable assets
It is pointed out that listed pharmaceutical companies are focusing on possessing cash in case of an emergency.
According to the YakupDotCom’s analysis result of cashable assets of 55 KOSDAQ and KOSPI listed pharmace...
Norvasc Tab 10mg has been out of stock for a while; it put financial pressure on patient-sharing medical expenses and the National Health Insurance budget
As the Pfizer’s Norvasc Tab 10mg has been out of stock since the end of the last year, it is expected to put pressure on patient-sharing medical cost and the National Health Insurance budget.
A pharmacy in Busan has ...
The size of the obesity treatment market increased 8% up, listing Furing and Dietamin in order
The last year’s size of the obesity treatment market has increased 8% up compared to the year before. Growth of psychotropic pharmaceutical products, phentermine-type medicines, has stood out.
However, blockbuster-le...
